Published in Lancet on April 18, 1992
Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor. J Virol (1997) 1.84
Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor. J Virol (1997) 1.42
Oral manifestations of hepatitis C virus infection. World J Gastroenterol (2014) 0.89
HCV and Sjögren's syndrome. Lancet (1992) 0.83
The GOR gene product cannot cross-react with hepatitis C virus in humans. Clin Exp Immunol (2001) 0.82
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol (2001) 19.07
Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion (1999) 5.67
Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology (1997) 5.53
Health services: an Italian market. Lancet (1996) 3.43
Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut (2004) 3.26
The treatment of portal hypertension: a meta-analytic review. Hepatology (1995) 3.11
Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol (2001) 2.93
Preoperative radiotherapy for resectable rectal cancer: A meta-analysis. JAMA (2000) 2.76
Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach. J Hepatol (2001) 2.36
Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther (2011) 2.34
Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C. Am J Gastroenterol (2011) 2.31
Smoking habits and recurrence in Crohn's disease. Gastroenterology (1994) 2.30
Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis (1999) 2.15
Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig Dis Sci (1991) 2.12
Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci (1986) 2.07
Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology (1999) 2.02
Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? Hepatology (2001) 1.99
Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther (2011) 1.95
Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann Intern Med (1992) 1.92
Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials. Ann Oncol (1997) 1.85
Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology (1998) 1.74
Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis. European Concerted Action on Viral Hepatitis (EUROHEP) Am J Gastroenterol (1998) 1.74
Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation. Aliment Pharmacol Ther (2011) 1.73
The long-term course of chronic hepatitis B. Hepatology (1999) 1.63
Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease. Gastroenterology (1991) 1.62
Chronic hepatitis C and interferon alpha: conventional and cumulative meta-analyses of randomized controlled trials. Am J Gastroenterol (1999) 1.60
Non-alcoholic fatty liver disease pathogenesis: the present and the future. Dig Liver Dis (2009) 1.58
Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index. Aliment Pharmacol Ther (2011) 1.58
Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis. Hepatology (1995) 1.57
Hepatitis C virus replication in 'autoimmune' chronic hepatitis. J Hepatol (1991) 1.52
Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal varices in patients with compensated hepatitis C virus cirrhosis. J Viral Hepat (2013) 1.51
Spontaneous bacterial peritonitis: a prospective investigation in predominantly nonalcoholic cirrhotic patients. Hepatology (1983) 1.49
TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials. Radiology (1999) 1.42
Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. The Investigators of the European Concerted Action on Viral Hepatitis (EUROHEP). J Hepatol (1994) 1.40
Interferon for non-A, non-B chronic hepatitis. A meta-analysis of randomised clinical trials. J Hepatol (1991) 1.40
The molecular nature of the F-actin binding activity of aldolase revealed with site-directed mutants. J Biol Chem (1996) 1.32
Biodistribution of an adenoviral vector carrying the luciferase reporter gene following intravesical or intravenous administration to a mouse. Cancer Gene Ther (1999) 1.28
Epidemiology, risk factors and surveillance of hepatocellular carcinoma. Eur Rev Med Pharmacol Sci (2010) 1.24
Liver transplantation: the Italian experience. Dig Liver Dis (2002) 1.19
Mortality and causes of death in celiac disease in a Mediterranean area. Dig Dis Sci (1999) 1.16
Long-term course of interferon-treated chronic hepatitis C. J Hepatol (1998) 1.15
Distal spleno-renal shunt versus endoscopic sclerotherapy in the prevention of variceal rebleeding. A meta-analysis of 4 randomized clinical trials. J Hepatol (1992) 1.14
Adriamycin treatment for hepatocellular carcinoma. Experience with 109 patients. Cancer (1985) 1.12
Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems. Aliment Pharmacol Ther (2008) 1.12
Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis. A prospective, randomized trial. Dig Dis Sci (1983) 1.12
Natural history of congestive gastropathy in cirrhosis. The Liver Study Group of V. Cervello Hospital. Gastroenterology (1990) 1.11
Pseudocysts in acute nonalcoholic pancreatitis: incidence and natural history. Dig Dis Sci (1999) 1.10
Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. European Concerted Action on Viral Hepatitis (EUROHEP). J Hepatol (1997) 1.09
State level estimates of the incidence and economic burden of head injuries stemming from non-universal use of bicycle helmets. Inj Prev (2002) 1.09
Occurrence of Australia antigen in chronic hepatitis in Italy. Gastroenterology (1972) 1.09
Delta agent and hepatocellular carcinoma. Prog Clin Biol Res (1983) 1.08
Ascites, pleural, and pericardial effusions in acute pancreatitis. A prospective study of incidence, natural history, and prognostic role. Dig Dis Sci (1996) 1.08
Long-term interferon-beta treatment for multiple sclerosis. Neurol Sci (2003) 1.06
The Italian experience on paediatric liver transplantation: 1988-1999 report. Dig Liver Dis (2002) 1.06
Early detection of hepatocellular carcinoma associated with cirrhosis by ultrasound and alfafetoprotein: a prospective study. Hepatogastroenterology (1988) 1.06
Gastric endoscopic features in portal hypertension: final report of a consensus conference, Milan, Italy, September 19, 1992. J Hepatol (1994) 1.05
Prevalence of antibodies to hepatitis C virus in hepatocellular carcinoma. Lancet (1989) 1.02
Sludge and stones in gallbladder after pregnancy. Prevalence and risk factors. J Hepatol (1987) 1.01
Hepatocellular carcinoma and non-alcoholic fatty liver disease: from a clinical to a molecular association. Curr Pharm Des (2010) 1.01
Urinary cadmium and blood pressure: results from the NHANES II survey. Environ Health Perspect (1991) 1.01
Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosis. Gut (2001) 1.00
Biliary sludge and gallstones in pregnancy: incidence, risk factors, and natural history. Ann Intern Med (1993) 0.99
Fulminant hepatic failure in adult onset Still's disease. J Rheumatol (1996) 0.97
Ultrasonography and alpha-fetoprotein in diagnosis of hepatocellular carcinoma in cirrhosis. Dig Dis Sci (1988) 0.97
TB screening and anti-TNF alpha treatment. Thorax (2005) 0.97
Leukemic ophthalmopathy: a report of 21 pediatric cases. Med Pediatr Oncol (1994) 0.96
Does an 'autoimmune' profile affect the clinical profile of chronic hepatitis C? An Italian multicentre survey. J Viral Hepat (2004) 0.96
Delta agent infection in acute hepatitis and chronic HBsAg carriers with and without liver disease. Gut (1984) 0.95
Hepatitis-C virus infection in Italy: a multicentric sero-epidemiological study (a report from the HCV study group of the Italian Association for the Study of the Liver). Ital J Gastroenterol (1991) 0.95
Interferon-alpha for chronic hepatitis C: an analysis of pretreatment clinical predictors of response. Hepatology (1994) 0.94
Decrease in HDV endemicity in Italy. J Hepatol (1997) 0.94
Seeding after radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis: a prospective study. Dig Liver Dis (2008) 0.93
Oral pathology in untreated coeliac [corrected] disease. Aliment Pharmacol Ther (2007) 0.93
Long-term efficacy of alpha-interferon in beta-thalassemics with chronic hepatitis C. Blood (1997) 0.92
Soluble adhesion molecules correlate with liver inflammation and fibrosis in chronic hepatitis C treated with interferon-alpha. Aliment Pharmacol Ther (1998) 0.92
Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients. J Viral Hepat (2013) 0.91
Lactitol in treatment of chronic hepatic encephalopathy. A meta-analysis. Dig Dis Sci (1993) 0.91
Mortality in patients with Crohn's disease. Scand J Gastroenterol (1996) 0.89
Serum hepatitis C virus (HCV)-RNA and response to alpha-interferon in anti-HCV positive chronic hepatitis. J Med Virol (1992) 0.89
Is autoimmune chronic active hepatitis a HCV-related disease? J Hepatol (1991) 0.89
Gross pathologic types of hepatocellular carcinoma in Italy. Oncology (1999) 0.89
Metastatic hepatocellular carcinoma of the parotid region without lung metastasis: a case report. Int J Oral Maxillofac Surg (2009) 0.89